The FDA (Food and Drug Administration) Has recently stated that it knows there’s demand for cannabis products in the marketplace, however they say that they are taking a “science-based” approach to determine the safety and efficacy of cannabis products as it considers how to handle their legality.
The FDA as of late has opened a public docket on cannabis as well as cannabis-infused products and held its first-ever hearings as it starts the process of figuring out if, and when, it will regulate the cannabis space.
In a message that was posted to the FDA website, the agency indicated an open-mindedness to the potentially benefits of cannabis and cannabis-derived substances. CBD(Cannabidiol), is the principal ingredient in one FDA-approved drug which is used for epilepsy in children called Epidiolex. But the agency has urged the public to try and understand its interest in analyzing evidence to further understand the cannabinoid before approving it.
Quote directly from the Food & Drug Administration:
“We recognize that there is significant public interest in these products, for therapeutic purposes and otherwise,” the FDA said. “At the same time, there are many unanswered questions about the science, safety, and quality of many of these products. As we approach these questions, we do so as a science-based regulatory agency committed to our mission of protecting and promoting public health.”
Among the possible issues that there may be with the use of CBD, the FDA wants to know more about whether cannabis causes liver problems. They also seem to be interested in whether cannabis-derived substances can be beneficial in veterinary medicine.
They have also indicated that its clear understanding that many in the health community think the plant may have therapeutic value.
“It is critical that we continue to do what we can to support the science needed to develop new drugs from cannabis,” – stated by the FDA. According to the FDA, they are currently reviewing written comments submitted to the public docket which was open until July 16th.
Now even though the FDA has approved the drug Epidiolex, the agency looks at substances on two parallel tracks – one of which being for drugs and one for food and dietary supplements. As of right now, it is illegal to sell foods to which CBD has been added, or to market it as a supplement.
The FDA has also stated that it’s serious about its consideration of CBD in food and other non-drug products.
Statement from the FDA:
“Our Agency is committed to science-based decision making when it comes to CBD, while also taking steps to consider if there are appropriate regulatory pathways for the lawful marketing of CBD, outside of the drug setting,”
Well good news for those who are either already veterans in the industry or who are just breaking into CBD. The FDA seems to be on the right track to push CBD into new and better territories creating pathways that will lead to further innovation of this amazing plant.